Meredith Manning, the Chief Commercial Officer of $SLNO, sold 2,100 shares of the company on 03-27-2026 for an estimated $65,180. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1% of their shares of this class of stock. Following this trade, they now own 65,065 shares of this class of $SLNO stock.
$SLNO Insider Trading Activity
$SLNO insiders have traded $SLNO stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $SLNO stock by insiders over the last 6 months:
- MEREDITH MANNING (Chief Commercial Officer) has made 0 purchases and 3 sales selling 7,522 shares for an estimated $228,979.
- MICHAEL F. HUANG (Sr. VP of Clinical Development) has made 0 purchases and 3 sales selling 6,582 shares for an estimated $200,364.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SLNO Hedge Fund Activity
We have seen 157 institutional investors add shares of $SLNO stock to their portfolio, and 116 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VIVO CAPITAL, LLC removed 1,383,294 shares (-60.7%) from their portfolio in Q4 2025, for an estimated $64,046,512
- JANUS HENDERSON GROUP PLC added 1,122,015 shares (+18.5%) to their portfolio in Q4 2025, for an estimated $51,949,294
- WELLINGTON MANAGEMENT GROUP LLP added 1,010,704 shares (+43.7%) to their portfolio in Q4 2025, for an estimated $46,795,595
- DEEP TRACK CAPITAL, LP added 1,000,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $46,300,000
- HOLOCENE ADVISORS, LP removed 997,069 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $46,164,294
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 899,157 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $41,630,969
- WOODLINE PARTNERS LP added 840,946 shares (+310.5%) to their portfolio in Q4 2025, for an estimated $38,935,799
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SLNO Analyst Ratings
Wall Street analysts have issued reports on $SLNO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 01/20/2026
- Wolfe Research issued a "Outperform" rating on 11/18/2025
To track analyst ratings and price targets for $SLNO, check out Quiver Quantitative's $SLNO forecast page.
$SLNO Price Targets
Multiple analysts have issued price targets for $SLNO recently. We have seen 5 analysts offer price targets for $SLNO in the last 6 months, with a median target of $85.0.
Here are some recent targets:
- Leland Gershell from Oppenheimer set a target price of $80.0 on 03/18/2026
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $100.0 on 03/04/2026
- Derek Archila from Wells Fargo set a target price of $110.0 on 02/27/2026
- Tyler Van Buren from TD Cowen set a target price of $85.0 on 02/26/2026
- Kalpit Patel from Wolfe Research set a target price of $75.0 on 11/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
